Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2025

About this update from Definitive Healthcare Corp.

[{"type":"image","alt":"Definitive Healthcare Corp.","displaySize":"","headline":null,"caption":"Definitive Healthcare Corp.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":61,"url":"https://media.zenfs.com/en/globenewswire.com/798d772fd35c853385447e0a83f343de"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/YMii1YNRhhXnoJKWXGC71g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTg1O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/798d772fd35c853385447e0a83f343de","width":300,"height":61}},"lazy":false},{"type":"text","content":"Third Quarter Revenue Delivered at High End of Guidance","length":55,"tagName":"p"},{"type":"text","content":"FRAMINGHAM, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended September 30, 2025.","length":271,"tagName":"p"},{"type":"text","content":"Third Quarter 2025 Financial Highlights:","length":40,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue was $60.0 million, a decrease of 4% from $62.7 million in Q3 2024.","length":74,"tagName":"p"}]},{"val":[{"type":"text","content":"Net Loss was $(17.8) million, or (30)% of revenue, compared to $(187.8) million in Q3 2024, inclusive of goodwill impairment charges of $228.2 million, or (300)% of revenue.","length":173,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted Net Income was $9.7 million, compared to $15.4 million in Q3 2024.","length":75,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted EBITDA was $18.9 million, or 32% of revenue, compared to $20.6 million, or 33% of revenue in Q3 2024.","length":110,"tagName":"p"}]},{"val":[{"type":"text","content":"Cash Flow from Operations was $15.7 million in the quarter.","length":59,"tagName":"p"}]},{"val":[{"type":"text","content":"Unlevered Free Cash Flow was $17.9 million in the quarter.","length":58,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":549,"olType":false},{"type":"text","content":"“We delivered third quarter results at or above the high end of our guidance ranges, with Adjusted EBITDA exceeding expectations by $2 million,” said Kevin Coop, CEO of Definitive Healthcare. “We continue to make steady progress across our strategic pillars, with ...

More updates from Definitive Healthcare Corp.